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JOURNAL OF HEPATOLOGYRepl y to: ‘‘Regular coffee: A mag ic bullet or a naked gun? 
Regular cof fee but not espresso dri nking is prot ective against 
ﬁbrosis in NAFLD’’To the Editor:
Filtered, ristretto, lungo and what else? 
We have read with interest the commen ts and criticism s made 
by Trovato and colleague s concerning our recently published 
study [1]. We would like to clarify a number of speciﬁc points.
Firstly, we agree that our study population – morbidly obese 
patients referred for bariatric surgery – is a very particular group;
morbidly obese subjects represent one percent of the French pop- 
ulation. Our patien ts were consecuti vely enrolled in the bariatric 
program and agreed to complete a detailed question naire, given 
by a trained interview er, assessing their coffee and caffeinate d
drink consumption . For each patient, a liver biopsy was obtained 
and assessed by validated classiﬁcation. This histological analysis 
remains the gold standard to determ ine the various elementary 
lesions of NAFLD and NASH. This method is reliable and allowed 
us to differen tiate pure steatosis, NASH, and the various degrees 
of ﬁbrosis, in contrast to the use of only non-invasi ve methods 
such as liver ultrasound, as in the study by Catalano et al. [2].
Secondly, as we stated in the Discussion, we do not know why 
the consump tion of ﬁltered regular coffee and not the consump- 
tion of espresso was associated with less ﬁbrosis, in our cohort of
morbidly obese patients. An initial hypothesis is that these two 
high-qual ity beverag es are different in their compos ition because 
of their speciﬁc manufactu ring process es. Another hypothesi s is
that regular and espresso drinkers have hidden, intrinsic differ- 
ences. For example, espresso drinkers could use a higher quantity 
of sugar or use special forms of sugar (enriched in fructos e for 
example). In our study, we found a positive correlation between 
the consumptio n of espresso and the number of parameters of
the metabolic syndrome, the level of triglycerid es, and a negative 
correlation with the level of HDL cholester ol. We must keep in
mind that if 6 g of sugar (the usual amount of sugar served with 
an espresso in France) is added to an espresso of 50 ml, the 
concentrati on of sugar (120 g/l) is slightly higher than a typical 
cola-based soft drink (35 g of sugar for 330 ml, i.e., 106 g/l). As
we stated in the Discussion , we did not take into account the 
amount and type of sugar added to coffee in the questionnair e,
and the last sentence of our paper was intended as a joke! Studies 
including more detail concern ing consump tion should answer 
this question, as was done in the Nutrinet study in France [3].Journal of Hepato logy 20Our study probably reﬂects the current mode of consump tion 
of coffee in France. The espresso drunk by our patien ts is essen- 
tially home-made using small machines, which are becoming 
more and more popular. The obtained beverag es are different 
from the ﬁltered coffee and possibly from the espresso made in
coffee shops [4]. The volume obtained with these machin es can 
vary from ‘‘ristretto’’ (25 ml), standard ‘‘espresso ’’ (40 ml) to
‘‘lungo’’ (110 ml). Moreover, in the case of the ‘‘espresso’’ made 
by professi onals, the quality of the obtained beverage can be very 
different, dependi ng on the coffee shop, in terms of caffeine ,
chlorogenic acid and probably in the content of other compounds 
[5]. So the term ‘‘espresso’’ designat es different beverages, and 
the delicious ‘‘ristretto espresso ’’ made in a traditio nal Italian cof- 
fee shop is probably different from the beverage currently 
obtained at home in France with a small coffee machine.
Thirdly, a questionn aire is an imperfec t way of collecting 
information but has been used extensively and validated in epi- 
demiologic al studies on coffee that include cohort studies [5].
With respect to our patients, it appeared that the daily consump- 
tion of coffee was regular over time and generally well recalled.
The multivaria te analysis has been performed using standard 
statistics. For logistic regression , non-redund ant paramet ers that 
are signiﬁcant in univariat e analysis were selected. The quantit y
of regular coffee consumed and the approximate amount of caf- 
feine from regular coffee were the same variable expressed in a
different way. The patients were asked the volume of the various 
kinds of coffee and other caffeinate d drinks consumed . A conver- 
sion table automat ically converted the amount of each drink into 
the amount of caffeine consumed . This is why only the equiva- 
lence in caffeine consumption was ﬁnally retained for multivari- 
ate analysis. Similarly, AST and ALT were linked togethe r. We
chose AST because it is also a marker of ﬁbrosis. In a model 
including AST and ALT, we obtained a similar result for regular 
coffee consump tion (OR = 0.76, 95% CI: 0.58–0.99, p = 0.041).
Fourthly, we recognize that we did not provide a complete 
nutritional and lifestyle assessment in our study. Howeve r,
known confounder s for coffee association , alcohol and tobacco 
use were assessed and were similar in patients with and without 
signiﬁcant ﬁbrosis.
Finally, our study is in accordanc e with the recent results of
Molloy et al. who found a beneﬁcial effect of ﬁltered coffee con- 
sumption on the level of ﬁbrosis of morbidly obese American 
patients [6]. As observed in our study, no effect was seen on13 vol. 58 j 1258–1266 1265 
[7] Bambha K, Wilson L, Unalp A, Loomba R, Neusc hwander-Tetri BA, Brunt EM,
et al. Coffee consumption in NAFLD patients with lower insulin resis tance is
associated with lower risk of severe ﬁbrosis. Hepatology 2012;56:242A.
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Letters to the Editor 
the degree of NASH. Bambha et al. also observed a beneﬁcial
effect of regular coffee consumptio n on liver ﬁbrosis in NAFLD 
patients, however, only in patients with a low level of insulin 
resistance [7]. The positive effect of ﬁltered coffee on overall mor- 
tality and on liver morbidity has also been demonstra ted in a
large number of studies.
Due to the changing ways of consuming coffee, new epidem i-
ological studies are necessary to better analyze the relationsh ips 
between coffee consump tion and liver diseases. Translation al
studies have to be performed to ﬁnd the mechan isms and sub- 
stance(s) of potential pharmacol ogical interest. We can wait 
(calmly) for these results while drinking some (mainly regular?)
coffee, probably without adding a sweetener and certainly with- 
out smoking cigarettes !
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